These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35757255)

  • 21. Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials.
    Mansour-Ghanaei F; Pourmasoumi M; Hadi A; Joukar F
    Integr Med Res; 2019 Mar; 8(1):57-61. PubMed ID: 30949432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
    Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
    J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.
    Jennison E; Byrne CD
    Clin Mol Hepatol; 2021 Jan; 27(1):22-43. PubMed ID: 33291863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Seong E; Bose S; Han SY; Song EJ; Lee M; Nam YD; Kim H
    EPMA J; 2021 Jun; 12(2):177-197. PubMed ID: 34194584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials.
    Qin S; Huang L; Gong J; Shen S; Huang J; Ren H; Hu H
    Nutr J; 2017 Oct; 16(1):68. PubMed ID: 29020971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associating gene expressions with curcuminoid biosynthesis in turmeric.
    Ayer DK; Modha K; Parekh V; Patel R; Vadodariya G; Ramtekey V; Bhuriya A
    J Genet Eng Biotechnol; 2020 Dec; 18(1):83. PubMed ID: 33315159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Mirhafez SR; Azimi-Nezhad M; Dehabeh M; Hariri M; Naderan RD; Movahedi A; Abdalla M; Sathyapalan T; Sahebkar A
    Adv Exp Med Biol; 2021; 1308():25-35. PubMed ID: 33861434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials.
    White CM; Lee JY
    Pharm Pract (Granada); 2019; 17(1):1350. PubMed ID: 31015871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin.
    Ghorbani Z; Hekmatdoost A; Mirmiran P
    Int J Endocrinol Metab; 2014 Oct; 12(4):e18081. PubMed ID: 25745485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
    Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
    World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative bioavailability of curcuminoids from a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study.
    Thanawala S; Shah R; Alluri KV; Somepalli V; Vaze S; Upadhyay V
    J Pharm Pharmacol; 2021 Apr; 73(6):816-823. PubMed ID: 33755149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Wei Z; Liu N; Tantai X; Xing X; Xiao C; Chen L; Wang J
    Hepatol Int; 2019 May; 13(3):302-313. PubMed ID: 30446932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome.
    Pérez-Torres I; Ruiz-Ramírez A; Baños G; El-Hafidi M
    Cardiovasc Hematol Agents Med Chem; 2013 Mar; 11(1):25-37. PubMed ID: 22721439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials.
    White CM; Pasupuleti V; Roman YM; Li Y; Hernandez AV
    Pharmacol Res; 2019 Aug; 146():104280. PubMed ID: 31121255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial.
    Panahi Y; Valizadegan G; Ahamdi N; Ganjali S; Majeed M; Sahebkar A
    J Cell Biochem; 2019 Sep; 120(9):15989-15996. PubMed ID: 31168845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel predict-verify strategy for targeted metabolomics: Comparison of the curcuminoids between crude and fermented turmeric.
    Xiang X; Song C; Shi Q; Tian J; Chen C; Huang J; She B; Zhao X; Huang R; Jin S
    Food Chem; 2020 Nov; 331():127281. PubMed ID: 32559596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    Saberi-Karimian M; Keshvari M; Ghayour-Mobarhan M; Salehizadeh L; Rahmani S; Behnam B; Jamialahmadi T; Asgary S; Sahebkar A
    Complement Ther Med; 2020 Mar; 49():102322. PubMed ID: 32147075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.